Nevro Corp
(NYSE:NVRO)
$
5.08
-0.26 (-4.87%)
Market Cap: 189.40 Mil
Enterprise Value: 157.99 Mil
PE Ratio: 0
PB Ratio: 0.69
GF Score: 44/100 Nevro Corp at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Transcript
Feb 25, 2021 / 06:30PM GMT
Release Date Price:
$167.14
(-2.21%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
Well, everybody, welcome back. I'm still Joanne Wuensch, and this is still the Citi Healthcare Conference. And we are moving towards Nevro and very, very pleased to have Keith Grossman, Rod MacLeod and Julie Dewey, all here today, fresh off their fourth quarter earnings call. Everyone, welcome.
D. Keith Grossman
Nevro Corp. - Chairman of the Board, CEO & President
Thanks, Joanne. Thanks for having us.
Questions & Answers
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
And I'm going to start big picture here, and then we'll whittle it down later, this morning. Keith, you've now been an Nevro for almost 2 years. And from an outsider, the company is oh so different. But I'll be curious what you're seeing and how it's evolved since you joined.
D. Keith Grossman
Nevro Corp. - Chairman of the Board, CEO & President
Well, I think there have been certainly a lot of changes and a lot of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot